Triazolo-pyridazine protein kinase modulators

Details for Australian Patent Application No. 2007309237 (hide)

Owner SGX Pharmaceuticals, Inc.

Inventors Smith, Christopher Ronald; Lee, Patrick S.; Jefferson, Elizabeth Anne; Bounaud, Pierre-Yves; Torres, Eduardo

Agent Spruson & Ferguson

Pub. Number AU-B-2007309237

PCT Pub. Number WO2008/051805

Priority 60/871,384 21.12.06 US; 60/913,752 24.04.07 US; 60/952,833 30.07.07 US; 60/862,552 23.10.06 US

Filing date 18 October 2007

Wipo publication date 2 May 2008

Acceptance publication date 22 March 2012

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/051805 Priority application(s): WO2008/051805

22 March 2012 Application Accepted

  Published as AU-B-2007309237

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309255-Biguanide composition with low terminal amine

2007309232-Visual prosthesis